| Product Code: ETC6751511 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Precision Oncology Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 China Precision Oncology Market - Industry Life Cycle |
3.4 China Precision Oncology Market - Porter's Five Forces |
3.5 China Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 China Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 China Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Technological advancements in precision oncology |
4.2.3 Government initiatives to promote precision medicine in oncology |
4.3 Market Restraints |
4.3.1 High costs associated with precision oncology treatments |
4.3.2 Limited access to advanced healthcare facilities in rural areas of China |
5 China Precision Oncology Market Trends |
6 China Precision Oncology Market, By Types |
6.1 China Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 China Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 China Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 China Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 China Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 China Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 China Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 China Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 China Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 China Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 China Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 China Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 China Precision Oncology Market Import-Export Trade Statistics |
7.1 China Precision Oncology Market Export to Major Countries |
7.2 China Precision Oncology Market Imports from Major Countries |
8 China Precision Oncology Market Key Performance Indicators |
8.1 Adoption rate of precision oncology treatments in China |
8.2 Number of precision oncology research studies conducted in China |
8.3 Percentage increase in funding for precision oncology initiatives in China |
9 China Precision Oncology Market - Opportunity Assessment |
9.1 China Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 China Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 China Precision Oncology Market - Competitive Landscape |
10.1 China Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 China Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here